Hearing Implants and Biomaterials Market Analysis, Key Players, Industry Segments And Forecast To 2023 - Cochlear, Med-EL, Sonova Group / Advanced Bionics

Global Hearing Implants and Biomaterial Market: Snapshot

Hearing implants and biomaterial markets are expected to witness a significant development in the coming years owing to growing use of next generation polymer, metals, and ceramics. This is expected to improve the value of the hearing surgery and optimize the surgical outcomes by enhancing people’s hearing with serious hearing problems.

Avail FREE sample report instantly @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313848

Inside Cochelar implants (CI) there are biomaterials that are inserted into the ear area to heal the hearing problem. All manufacturers of CI utilize platinum contacts in production electrode. The CI has been widely recognized as a well set treatment for serious hearing loss. This expected to drive market growth as there less than one percent of market penetration in the present scenario. Moreover, greater surgeon experience and new material are projected to cut down the cost of the implants in terms of device as well as the procedure. This trend is expected to continue as CI are to be used extensively as medical devices to aid profound hearing issues.

The 2017 study has 162 pages, 88 tables and figures. Hearing Implants and Biomaterial markets are poised to achieve significant growth with increasing use of next generation metals, polymers, and ceramics set to enhance the value of hearing surgery and improve surgical outcomes. By improving hearing of people with profound hearing deficits. Improvements is hearing for severely deaf infants, children and adults particularly old people are dramatic.

Small implant, great results is the norm. The best results were found among children who received the cochlear implant at 0-3 years of age. They achieved 90 to 95 percent hearing and language improvement. 80-90 percent of these children develop a hearing and speech equal to those of children with normal hearing.

Biomaterials inside CI are biological materials that are implanted into the ear area to repair hearing. All CI manufacturers use platinum contacts in electrode production. Iridium oxide coatings have been investigated, which show beneficial effects of impedance.

Get Complete Report With TOC With Tables and Figures @ https://www.researchmoz.us/hearing-implants-and-biomaterials-market-shares-strategies-and-forecasts-worldwide-2017-to-2023-report.html

Biomaterials for hearing implants depend on components, structural polymers, and electrodes. Biomaterials have transformed medical treatment of hearing loss. The ear functioning, hearing loss is able to be addressed with functioning repaired via a device implant that leverages biomaterials.

The cochlear implant has become widely recognized as an established treatment for profound hearing loss. This bodes well for market growth, as there is minimal, less than one percent market penetration now. New materials and greater surgeon experience are expected to reduce the cost of the implant, both the device and the procedure.

Economies of scale always decrease costs and increase market size. The trend likely to continue is for Cochlear implants as medical devices to continue to be used more often. Implants bypass damaged structures in the inner ear and directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.

Cochlear implants are not indicated for all hard of hearing or deaf people. They are not recommended in people who function well with hearing aids.

The implant works by picking up incoming sounds. Incoming sounds are converted to electrical currents and directed to a number of contact points on the internal wire. This operation creates an electrical field which directly stimulates the auditory nerve, thus bypassing the defective inner ear. Cochlear implants convert sound waves to electrical impulses and transmit them to the inner ear, providing people with the ability to hear sounds and potentially better understand speech without reading lips.

According to Susan Eustis, lead author of the team that prepared the study, “Cochlear implants extend the medical device markets by enabling a bypass of damaged structures in the inner ear. They directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.”

The worldwide market for Hearing Implants and associated biomaterials is $1.8 billion in 2017, anticipated to reach $5.8 billion by 2023. The complete report provides a comprehensive analysis of hearing implants in different categories, illustrating the diversity of uses for devices in auditory surgery by age group. A complete procedure analysis is done, looking at numbers of procedures and doing penetration analysis.

Get Reasonable Discount on This Premium Report @ https://www.researchmoz.us/enquiry.php?type=D&repid=1313848

Companies Profiled

Market Leaders

Cochlear
Med-EL
Sonova Group / Advanced Bionics

Market Participants

Nurotron
Biotechnology
William Demant / Oticon Medical / Neurelec

Key Topics

Biomaterials for Hearing Implants
Alpha Titanium Alloys
Near Alpha Titanium Alloys
Alpha-Beta Titanium Alloys
Annealing - Beta Titanium Alloys
Convert sound waves
Stimulates the auditory nerve
Electrical field
Sounds are converted to electrical currents
Profound hearing losses
Improve hearing in people
Stimulate the auditory nerve
Inner ear
Bypass damaged structures
Profound hearing loss

Table of Contents

Hearing Implants Biomaterials Market Driving Forces 12
Surgical Cochlear Implantation Is By And Large Safe 13
Hearing Implant Market Shares 15
Hearing Implant Biomaterials Market Forecasts 18

1. Biomaterials for Hearing Implants: Market Description and Market Dynamics 21
1.1 Use Of Cochlear Implants 21
1.2 Ear Description 25
1.2.1 Cochlear Implant (CI) System 26
1.2.2 Biomaterial As A Substance 27
1.3 Bilateral CI Fitting 30
1.4 Cochlear Implants Biomaterials 30
1.4.1 Silicone 31
1.4.2 Platinum 33
1.4.3 Titanium 33
1.4.4 Ceramics 35
1.5 Biomaterials in Hearing Implant 36

2. Hearing Implants and Biomaterials Market Shares and Forecasts 41
2.1 Hearing Implants and Biomaterials Market Driving Forces 41
2.1.1 Surgical Cochlear Implantation Is By And Large Safe 42
2.2 Hearing Implant Market Shares 44
2.2.1 Cochlear 48
2.2.2 Advanced Bionics AG 49
2.2.3 Med-EL EAS 50
2.3 Biomaterials Market Forecasts 50
2.3.1 Biomaterial Hearing Implant Segments, Children, Adults Age 19 to 50, Adults 51 to 64, Adults Over 65, Market Forecasts 56
2.3.2 Biomaterial Hearing Implant Market Installed Base Forecasts 59
2.4 Global Biomaterials Market 60
2.4.1 Optimizing the Biocompatibility Properties Of The Hearing Implant 64
2.4.2 Biofilms 66
2.4.3 Teflon for Cochlear Implants 67
2.4.4 Electrically Conducting Polymers 67
2.4.5 Polyimides 68
2.4.6 Silicon Electrodes 68
2.4.7 Physical Functionalization Of Surfaces 69
2.4.8 Drug Delivery In The Inner Ear (Neurotrophic Effects) 70
2.4.9 BioMaterial Nanoparticles 70
2.4.10 Nanoparticles And Cochlear Implants 71
2.4.11 Biomaterials Market Overview 71
2.5 Cochlear (CI) Implant Technical Specifications 77
2.5.1 Advanced Bionics Technical Specifications 77
2.5.2 Cochlear Technical Specifications 78
2.6 Biomaterials Pricing 79
2.7 Biomaterials Regional Segment Analysis 79
2.7.1 United States 81
2.7.2 Europe 83
2.7.3 Rapid Development of Middle Class in South America 84

3. Biomaterial Hearing Implants Product Description 91
3.1 Cochlear 91
3.1.1 Cochlear Kanso™ Sound Processor 95
3.1.2 Cochlear Nucleus® 6 Sound Processor 96
3.1.3 Cochlear Hearing Implant Specifications 97
3.1.4 Cochlear Implant Technical Specifications 101
3.2 Med-El GmbH’s Flex EAS 102
3.2.1 Med-EL EAS™ Hearing Implant System for Partial Mild To Moderate Deafness 102
3.2.2 Hearing Implant Advantages Of Bilateral Implantation 103
3.2.3 MedEL Implant Concerto 106
3.2.4 MedEL Implant Concerto Structure Preservation 107
3.2.1 MedEL Implant Concerto Complete Cochlear Coverage CCC 108
3.2.2 Med-EL Electrode Arrays 109
3.2.3 Med-EL FLEX Tip Technology 112
3.2.4 Med-EL Classic Series 114
3.2.5 Med-EL FLEX Series 114
3.2.6 FDA Approves the MED-EL Synchrony EAS Hearing Implant System 115
3.2.7 Med-EL Addresses Hearing Loss in the US 117
3.2.8 MED-EL Technical Specifications 118
3.3 Sonova / Advanced Bionics AG 119
3.3.1 Advanced Bionics Implant Specifications 120

Have Any Query? Ask to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=1313848



This release was published on openPR.